VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Kligman's formula (trio)
Approved
G
Ghurki Trust and Teaching Hospital
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[2]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Melasma
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Melasma
Approved
Completed
Clinical
Trials by Indication
[1]
Melasma
1 trial
Efficacy of New Trio Combination Versus Kligman's Formula In Treatment of Melasma
Completed
·
G
Ghurki Trust and Teaching Hospital
·
Approved
·
NCT07676994
·
56 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Kligman's formula (trio). U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform
—
Drug–disease associations for Kligman's formula (trio). EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR
—
Ghurki Trust and Teaching Hospital company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Highest Phase
Approved
[1]
Company
G
Ghurki Trust and Teaching Hospital
Related News